butabarbital decreases consequences of sufentanil SL by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Modify Therapy/Keep track of Intently. Coadministration of CYP3A4 inducers may possibly lower sufentanil levels and efficacy, quite possibly precipitating withdrawal syndrome in patients th